PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Division of Nephrology, Hypertension and Renal Transplantation, Department of Medicine (R.K.S.), University of Florida College of Medicine, Gainesville.\', \'Department of Physiology and Functional Genomics (B.R.S., E.M.R., M.K.R.), University of Florida College of Medicine, Gainesville.\', \'Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis (A.G.O.).\', \'Department of Ophthalmology and Visual Sciences, University of Alabama College of Medicine, Birmingham (M.B.G.).\', \'Department of Medicine, University of Alberta College of Medicine, Edmonton, Canada (G.Y.O.).\', \'Department of Ophthalmology (Q.L.), University of Florida College of Medicine, Gainesville.\', \'Division of Cardiovascular Medicine, Department of Medicine (C.J.P.), University of Florida College of Medicine, Gainesville.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1161/HYPERTENSIONAHA.120.15595
?:doi
?:hasPublicationType
?:journal
  • Hypertension (Dallas, Tex. : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 32783758
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all